Minakem Generic APIs Minakem Generic APIs

X

Find Diphosphonate, Technetium Methylene manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Diphosphonate, Technetium Methylene
Also known as: 8v3fgc4j77, Technetium tc-99m medronate anhydrous, Tc-99m-diphosphonate, Technetium diphosphonate, Tc-mdp, Tc-mdp tc-99m
Molecular Formula
CH2O6P2Tc
Molecular Weight
270.88  g/mol
InChI Key
DDVFLVSIVNKSLB-IEOVAKBOSA-J
FDA UNII
8V3FGC4J77

Technetium Tc-99m Medronate is a radiopharmaceutical containing methylene diphosphonate (medronate; MDP) complexed with the gamma-emitting radionuclide technetium Tc 99m with radioisotopic activity and hydroxyapatite affinity. Upon intravenous administration, skeletal uptake of technetium Tc 99m methylene diphosphonate occurs as a function of skeletal blood flow and osteogenic activity. The MDP moiety of this agent has affinity for hydroxyapatite crystals in bone with abnormal accumulation at sites with increased osteoid mineralization; labeling of MDP with Tc 99m allows scintigraphic imaging of areas of abnormal osteogenesis associated with malignant bone lesions.
1 2D Structure

Diphosphonate, Technetium Methylene

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
dioxido-oxo-(phosphonatomethyl)-5-phosphane;technetium-99(4+)
2.1.2 InChI
InChI=1S/CH6O6P2.Tc/c2-8(3,4)1-9(5,6)7;/h1H2,(H2,2,3,4)(H2,5,6,7);/q;+4/p-4/i;1+1
2.1.3 InChI Key
DDVFLVSIVNKSLB-IEOVAKBOSA-J
2.1.4 Canonical SMILES
C(P(=O)([O-])[O-])P(=O)([O-])[O-].[Tc+4]
2.1.5 Isomeric SMILES
C(P(=O)([O-])[O-])P(=O)([O-])[O-].[99Tc+4]
2.2 Other Identifiers
2.2.1 UNII
8V3FGC4J77
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Tc-99m-diphosphonate

2. Technetium Diphosphonate

3. Technetium Tc 99m Diphosphonate

2.3.2 Depositor-Supplied Synonyms

1. 8v3fgc4j77

2. Technetium Tc-99m Medronate Anhydrous

3. Tc-99m-diphosphonate

4. Technetium Diphosphonate

5. Tc-mdp

6. Tc-mdp Tc-99m

7. Technetium Tc 99m Diphosphonate

8. Technetium Tc-99m Diphosphonate

9. Diphosphonic Acid, Technetium-99tc Salt

10. Q27271059

11. Dioxido-oxo-(phosphonatomethyl)-lambda5-phosphane;technetium-99(4+)

12. Phosphonic Acid, Methylenebis-, Technetium(4+) Salt (1:1)

13. Phosphonic Acid, Methylenebis-, Technetium(4+)-99tc Salt (1:1)

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 270.88 g/mol
Molecular Formula CH2O6P2Tc
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count6
Rotatable Bond Count0
Exact Mass270.838911 g/mol
Monoisotopic Mass270.838911 g/mol
Topological Polar Surface Area126 Ų
Heavy Atom Count10
Formal Charge0
Complexity129
Isotope Atom Count1
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Radiopharmaceuticals

Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) (See all compounds classified as Radiopharmaceuticals.)


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY